Site Members can sign up for company wide alerts
Investigation Overview
An investigation on behalf of former and current employees of Repros Therapeutics, Inc. (Public, NASDAQ: RPRX) concerning potential Employee Retirement Income Security Act (ERISA) Breach of Fiduciary Duty was announced. Repros Therapeutics, Inc. has been accused of securities fraud and according to a an investigation by a law firm under ERISA employees (former and current) of Repros T...
You must register (for free) or login to view the entire investigation.